95253 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
ORGANIC ELECTROLUMINESCENT DEVICE AND INDOLE DERIVATIVE
#4802PURINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS FOR THE TREATMENT OF PLASMODIUM RELATED DISEASES
#4803Anti-Viral Compounds
#4804Pyrimidine hydrazide compounds as PGDS inhibitors
#4805Quinazolines for PDK1 inhibition
#4806PYRIMIDINE COMPOUNDS HAVING TIES (TEK) INHIBITORY ACTIVITY
#4807Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors
#4808PROTEIN INTERACTION REPORTER AGENTS AND METHODS FOR USING SAME
#4809Crystal modifications-3-(1-indol-3-yl)-4- [4-methyl-piperazin-1-yl)-quinazolin-4-yl] -pyrrole-2, 5-D ione
#4810Indolylmaleimide derivatives processes for their production and pharmaceutical compositions
#4811Methods for the use of pyrimidine derivatives which are antagonists of vitronectin receptor
#4812Organic Compounds as Smo Inhibitors
#4813New Heterocyclic bridged biphenyls
#48142 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical Compositions
#48152-SUBSTITUTED PROLINE BIS-AMIDE OREXIN RECEPTOR ANTAGONISTS
#4816HCV protease inhibitors and uses thereof
#4817NOVEL PYRIDAZINE DERIVATIVES
#4818Chemokine receptor modulators
#4819Compounds and compositions as protein kinase inhibitors
#4820Indolylamides as modulators of the EP2 receptor
#4821Amidophenoxyindazoles useful as inhibitors of c-Met
#4822Aminopyrimidines useful as inhibitors of protein kinases
#4823Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
#4824Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
#4825PYRAZOLYLAMINO SUBSTITUTED QUINAZOLES FOR THE TREATMENT OF CANCER
#4826ARYLMETHYLENE UREA DERIVATIVE AND USE THEREOF
#4827Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIA inhibitors
#4828Minor groove binders
#4829Polyamides containing amino butyric acid-based building blocks
#4830METHOD FOR PRODUCING PYRROLIDINE COMPOUND
#4831CB1 receptor modulators
#4832Pyrimidine Derivatives
#4833Quinazoline derivatives
#4834Heterocyclic compound
#4835Pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto
#4836Pharmaceutical compounds
#4837Inhibitors of Burton's tyrosine kinase
#4838Heteroaryl-substituted imidazole compounds and uses thereof
#4839Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#4840Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
#4841FORMULATIONS CONTAINING PYRIDAZINE COMPOUNDS
#4842Gyrase inhibitors and uses thereof
#48432-BENZIMIDAZOLYL-6-MORPHOLINO-4-PHENYLPYRIMIDINE DERIVATIVES AS PI3K AND MTOR INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
#4844Gyrase inhibitors and uses thereof
#4845Biocompatible crosslinked hydrogels, drug-loaded hydrogels and methods of using the same
#4846Aromatic AZA heterocycles, method of production and use of the material in organic electronics
#4847Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#4848Water-soluble CC-1065 analogs and their conjugates
#4849SUBSTITUTED RING FUSED AZINES AND THEIR USE IN CANCER THERAPY
#4850Pyridine derivatives as mGluR2 antagonists
#4851Indolylmaleimide derivatives
#4852PDF INHIBITORS
#4853Inhibitors of protein kinases
#48544-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
#4855Pyrazole compounds useful as protein kinase inhibitors
#4856Triazine-based monomeric compound, di-triazine compound, and degradable polymer
#4857Stabilizer mixtures
#4858Dimeric small molecule potentiators of apoptosis
#4859ANTI-INFLAMMATORY MEDICAMENTS
#4860Quinazolines useful as modulators of ion channels
#4861Cyclic amine bace-1 inhibitors having a heterocyclic substituent
#4862Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3
#4863Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
#4864High penetration prodrug compositions of peptides and peptide-related compounds
#4865Methods for treating papilloma virus infection
#4866PHOSPHODIESTERASE 4 INHIBITORS
#4867Peptide deformylase inhibitors
#48682-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
#4869ALKOXY INDOLINONE BASED PROTEIN KINASE INHIBITORS
#4870TRIAZINE COMPOUNDS AS PI3 KINASE AND MTOR INHIBITORS
#4871Organic electroluminescence element material, organic electroluminescence element, display device and lighting apparatus
#4872Inhibitors of protein kinases
#4873Triazine compounds as PI3 kinase and mTOR inhibitors
#4874Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
#4875Macrocyclic compounds and their use as kinase inhibitors
#4876Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
#4877Prodrugs of CC-1065 analogs
#4878Dimeric small molecule potentiators of apoptosis
#4879Benzoimidazole compound capable of inhibiting prostaglandin D synthetase
#4880HETEROAROMATIC DERIVATIVES USEFUL AS ANTICANCER AGENTS
#4881PHOTOCHROMIC PROBES
#4882Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors
#48832-HETEROCYCLOAMINO-4-IMIDAZOLYLPYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION
#4884Hepatitis C virus inhibitors
#4885AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE
#48862,3-dihydro-iminoisoindole derivatives
#4887PYRAZOLE PYRAZINE AMINE COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS THEREOF AND METHODS OF TREATMENT THEREWITH
#4888PYRIMIDINE DERIVATIVES
#4889Substituted dihydropyrazolones and their use
#4890Inhibitors of glutaminyl cyclase
#4891Pyrimidine compounds for combating pathogenic fungi and cancer
#4892Pyridazinone glucokinase activators
#4893Method of treating disease states using substituted pyrazole compounds
#4894Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
#4895DIPEPTIDE MIMICS, LIBRARIES COMBINING TWO DIPEPTIDE MIMICS WITH A THIRD GROUP, AND METHODS FOR PRODUCTION THEREOF
#4896Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives
#4897Substituted imidazole derivatives
#4898Antiviral compounds
#4899Novel organic electroluminescent compounds and organic electroluminescent device using the same
#4900Fused hetrocyclic compounds
#4901Substituted Pyrazoles as Ghrelin Receptor Antagonists
#4902Luminous Compound Containing Lanthanide Ion
#4903BENZOTHIOPHENE COMPOUNDS HAVING ANTIINFECTIVE ACTIVITY
#4904Indazole Derivatives for Treatment of Alzheimer's Disease
#4905Compounds, methods, complexes, apparatuses and uses relating to stabile forms of NAD/NADH
#4906Substituted 4-hydroxypyrimidine-5-carboxamides
#4907PYRAZOLE COMPOUNDS AS PROSTAGLANDIN RECEPTORS LIGANDS
#4908Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound
#4909SUBSTITUTED HETEROCYCLES AS ANTI-INFECTIVES
#4910Pyrazine-2-carboxyamide derivatives
#4911IMIDAZOLO-5-YL-2-ANILO-PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION
#4912Hepatitis C virus inhibitors
#4913Organic compounds
#49142-(cyclic amino)-pyrimidone derivatives
#4915VLA-4 inhibitory drug
#4916Aminopyrimidine Derivatives Inhibiting Protein Kinase Activity, Method For The Preparation Thereof And Pharmaceutical Composition Containing Same
#49172-anilino-4-(heterocyclic)amino-pyrimidines
#4918Substituted imidazole compound and use thereof
#4919N-(Hetero)Aryl Indole Derivatives as Pesticides
#4920Photorefractive dendron compound, photorefractive dendrimer compound, method of preparing the same, photorefractive device using the same, and method of manufacturing the device
#4921Pyrazole compounds as RAF inhibitors
#4922Substituted pyrimidines useful as protein kinase inhibitors
#4923Triazole derivatives as modulators of dopamine D3 receptors
#49245-lipoxygenase-activating protein (FLAP) inhibitors
#4925Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors
#4926Substituted Quinazoline Derivatives as Inhibitors of Aurora Kinases
#4927MODULATORS FOR AMYLOID BETA
#4928SOLUBLE GUANYLATE CYCLASE ACTIVATORS
#49292-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
#4930Nonpolar phase-soluble methathesis catalysts
#49315-substituted indazoles as kinase inhibitors
#4932Hepatitis C virus inhibitors
#4933Hepatitis C virus inhibitors
#4934Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi and Agents Containing Said Compounds
#4935Fluorinated tripeptide HCV serine protease inhibitors
#4936Vanilloid receptor ligands and their use in treatments
#4937Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof
#4938Substituted diazepan orexin receptor antagonists
#4939IAP BIR domain binding compounds
#4940Organic compound, charge-transporting material, and organic electroluminescent element
#4941Indole, azaindole and related heterocyclic pyrrolidine derivatives
#4942SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
#4943Aminopyrimidines useful as kinase inhibitors
#4944Thrombopoietin mimetics
#4945HCV protease inhibitors and uses thereof
#4946Substituted quinoxalines, their preparation and their therapeutical use as 11βHSD1 modulators
#4947Gyrase inhibitors and uses thereof
#4948Pyridinone and pyridazinone derivatives as inhibitors of poly (ADP-ribose) polymerase (PARP)
#4949Tricyclic compounds
#4950Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
#4951Thrombopoietin mimetics
#4952AUTOMATED SOLID PHASE SYNTHESIS OF PYRROLE-IMIDAZOLE POLYAMIDE
#49532,4-pyrimidinediamine compounds and their uses
#49542,4-pyrimidinediamine compounds and their uses
#4955Benzimidazole derivatives and their use as a medicament
#4956Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor
#4957Compounds for the treatment of inflammatory disorders
#4958Compounds and Their Pharmaceutical Use
#4959Pyridazinone derivatives useful as glucan synthase inhibitors
#4960Viral polymerase inhibitors
#4961Azetidine Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
#4962Chemokine receptor antagonists and use thereof
#4963Organic electroluminescent device material, organic electroluminescent device, display and illuminating device
#4964CATIONIC LIPIDS
#4965Compounds useful as antagonists of CCR2
#4966Substituted oxindole derivatives, drugs containing said derivatives and the use thereof
#4967Fused bicyclic mTor inhibitors
#4968Pyrimidines as PLK inhibitors
#4969Triazole derivative, light-emitting element, light-emitting device, and electronic device
#49702,4-pyrimidinediamine compounds and their uses
#4971Substituted imidazole compound and use thereof
#4972Fungicidal azocyclic amides
#4973Compounds for the treatment of inflammatory disorders
#4974Thrombopoietin mimetics
#4975Heterocyclic compound and organic electroluminescent device using the same
#4976Monocyclic Heteroaryl compounds
#4977Aminopyridine derivatives having aurora a selective inhibitory action
#4978Tyrosine Kinase Inhibitors
#4979Pyrimidines as PLK inhibitors
#4980Vanilloid receptor ligands and their use in treatments
#4981Protein Kinase Inhibitors
#4982Indoles, Derivatives, and Analogs Thereof and Uses Therefor
#4983INDAZOLYLAMINO QUINAZOLINE DERIVATIVES AS ANTITUMOUR AGENTS
#4984Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
#4985Heterocyclic amide compound and use thereof
#4986Compounds for the treatment of inflammatory disorders
#4987Carbazole-containing materials in phosphorescent light emitting diodes
#4988Caprazene as a novel compound and derivatives thereof, and caprazol as a novel compound and derivatives thereof
#4989NOVEL COMPOUNDS
#4990Pharmaceutically active compounds containing tetrazolyl and triazolyl rings
#4991DISUBSTITUTED UREAS AS KINASE INHIBITORS
#4992Pyrimidine Derivatives
#4993Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels
#4994Platinum complex compound and organic electroluminescent device
#49953-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors
#4996Pyrazole derivatives as kinase inhibitors
#4997Novel Bicyclic Sulfonamides for Use as Glucocorticoid Receptor Modulators in the Treatment of Inflammatory Diseases
#4998Pyrazolo quinazoline derivatives, process for their preparation and their use as kinase inhibitors
#4999HYDROXYAMIC ANALOGS AS HEPATITIS C VIRUS SERINE PROTEASE INHIBITOR
#5000BIS-ALKYLATING AGENTS AND THEIR USE IN CANCER THERAPY
#5001Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase
#5002Compounds that are ERK inhibitors
#5003ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN
#5004Proline bis-amide orexin receptor antagonists
#5005Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
#5006AMIDE LINKED HETEROAROMATIC DERIVATIVES AS MODULATORS OF MGLUR5
#50071,2,3-TRIAZOLE PYRROLIDINE DERIVATIVES AS MODULATORS OF MGLUR5
#5008Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
#5009Multimers of Heterocyclic Compounds and Their Use
#5010Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
#5011Chiral cis-imidazolines
#5012Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
#5013Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors
#5014Organic compounds
#5015Benzazepine derivatives for the treatment of neurological disorders
#50162-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
#5017Btk protein kinase inhibitors
#5018Substituted piperazines as CB1 antagonists
#5019Smac mimetic dimers and trimers useful as anti-cancer agents
#5020Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
#5021INDAZOLE COMPOUNDS AND METHODS OF USE THEREOF
#5022Protein Kinase Inhibitors
#50234-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors
#5024N-AROYL CYCLIC AMINES
#5025miRNA PROCESSING INHIBITOR EFFICACY ASSAYS AND SUBSTANCES
#5026Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
#5027COMPOUND CONTAINING FUSED RING AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME
#5028Tetraphenylene compounds for organic electroluminescent device
#5029Purinone derivatives as HM74A agonists
#5030Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
#5031Intermediates for making 2,4-pyrimidinediamine compounds
#5032Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
#5033METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY
#5034Novel Sulphur-Containing Cyclic Urea Derivatives, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors
#5035Process for synthesis of pyrrole derivative, an intermediate for atorvastatin
#5036BICYCLIC HETEROARYL DERIVATIVES
#5037Organic electroluminescent device
#5038Methine dyes and uses of the same
#5039Purinone derivatives as HM74A agonists
#5040Kinase inhibitor compounds
#5041CLICK CHEMISTRY ROUTE TO TRIAZOLE DENDRIMERS
#5042Pyrazole-based cyanine dye
#5043AZACYCLYLISOQUINOLINONE AND ISOINDOLINONE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS
#5044Pyridazine based alpha-helix mimetics
#5045COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
#5046Phthalazinone derivatives
#5047ISOQUINOLINYL AND ISOINDOLINYL DERIVATIVES AS HISTAMINE-3 ANTAGONISTS
#5048Linear and cyclic melanocortin receptor-specific peptidomimetics
#5049Hepatitis C virus inhibitors
#5050Isatin analogues and uses therefor
#5051Imidazoyl pyridine compounds and salts thereof
#5052Small molecule PI 3-kinase inhibitors and methods of their use
#5053Pyrrolidine aryl-ether as NK3 receptor antagonists
#5054COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS
#50552,3-disubstituted pyrazinesulfonamides as CRTH2 inhibitors
#5056Nitrogen-containing heterocyclic compound
#5057Phthalazine compounds, compositions and methods of use
#5058Indazolinone compositions useful as kinase inhibitors
#5059Antiviral compounds
#5060Process for synthesizing compounds useful for treating hepatitis C
#5061Inhibitors for steroid response elements and related methods
#5062Aminopyrimidine Derivative and Plant Disease Control Agent for Agricultural or Horticultural Use
#5063AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR BETA-SECRETASE MODULATION
#50644-benzimidazol-2-ylpyridazin-3-one derivatives
#5065Tubulin Binding Anti Cancer Agents And Prodrugs Thereof
#5066Benzimidazole derivatives and their use for modulating the GABAreceptor complex
#5067Quinazoline derivatives for use against cancer
#5068N-aroyl cyclic amine derivatives as orexin receptor antagonists
#5069Five-membered heterocycles useful as serine protease inhibitors
#5070Modified carbocyanine dyes and their conjugates
#5071Modified carbocyanine dyes and their conjugates
#5072SUBSTITUTED PYRAZOLE COMPOUNDS
#5073N-aroyl cyclic amines
#5074Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
#5075Large stoke shift NIR dyes
#5076DIAMINOPYRIMIDINES AS MODULATORS OF THE EP2 RECEPTOR
#5077Organic compound, charge transport material and organic electroluminescent device
#50785-lipoxygenase-activating protein (FLAP) inhibitors
#5079N-aroyl cyclic amine derivatives as orexin receptor antagonists
#5080Bicyclic derivatives as modulators of ion channels
#5081New Aza-Bicyclohexane Compounds Useful As Inhibitors Of Thrombin
#5082N-aroyl cyclic amine derivatives as orexin receptor antagonists
#5083N-aroyl cyclic amines
#5084MULTINUCLEAR COMPLEX AND POLYMER THEREOF
#5085Gas generant compositions
#5086Benzimidazole derivatives
#5087Indolylmaleimide derivatives
#5088N-aroyl cyclic amine derivatives as orexin receptor antagonists
#50891,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle
#5090Methods for treating cancer
#5091Triheterocyclic compounds and compositions thereof
#5092Labels, their production process and their uses
#5093Indole and benzimidazole derivatives
#5094Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#5095Substituted pyrazines for use in the treatment of inflammatory or allergic conditions
#50967-pyrazolylbenzazepines having affinity for D3 receptor
#5097Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#5098Hepatitis C virus inhibitors
#5099Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation
#51001-Benzazepine-3-Sulfonylamino-2-Pyrroridones as Factor Xa Inhibitors